Announced Tue, 9 Jun · 18:27 IST

Notice of Extra Ordinary General Meeting

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.4%1-day move
₹76.99
prior close
₹79.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.7-7.7-7.7-5.5+4.4+8.7+10.4+13.7+9.6-1.5+2.1-13.6
Up moveDown movePending
AI summary

Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has called an Extra Ordinary General Meeting (EGM) on July 1, 2026 at 3:30 PM via video conferencing. The single item on the agenda is a Special Resolution to issue up to 12,00,000 equity shares of face value Rs. 10 each at Rs. 57 per share (including Rs. 47 premium) on a preferential basis to 18 non-promoter individuals/entities, raising Rs. 6.84 crore. The proceeds will be used for lab-scale technology transfer from GMBU Germany (Rs. 75 lakh), land lease deposit at Siddipet (Rs. 100 lakh), land development (Rs. 188 lakh), consumables (Rs. 100 lakh), pre-operative expenses (Rs. 125 lakh), quality control equipment (Rs. 61 lakh), and travel/accommodation for German technical experts (Rs. 35 lakh), with deployment targeted before September 30, 2026. The relevant date for pricing is June 1, 2026 and e-voting cut-off date is June 24, 2026.

Likely market impact

If approved, the preferential allotment will dilute existing shareholders by issuing new shares to non-promoters, bringing in fresh capital of Rs. 6.84 crore. Existing shareholders should review the use of proceeds (largely tied to a new technology transfer project involving micro-algae cultivation) and the issue price before voting. The shares will be subject to SEBI-mandated lock-in periods.